MedTrace Logo

Pilot Study of the Entarik System With Advanced Functionality in Health Adults

NCT06660758 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2025-07-11

No results posted yet for this study

Summary

In this single-site study, data will be recorded during nasogastric or orogastric placement (and post-pyloric placement) and removal of the Entarik Feeding Tube. Data will also be collected prior to, during, and following the delivery of a meal through the feeding tube.

Conditions

  • Healthy Adults

Interventions

DEVICE

Feeding tube (Entarik)

Feeding tube placement will be verified using multiple methods in the duodenum and stomach.

Sponsors & Collaborators

  • Theranova, L.L.C.

    collaborator INDUSTRY

  • Gravitas Medical, Inc.

    lead INDUSTRY

Principal Investigators

  • Thomas Sorrentino, MD

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-10-22
Primary Completion
2025-12-21
Completion
2025-12-22
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06660758 on ClinicalTrials.gov